Effect of Cytotoxic Drugs in Frequently Relapsing Nephrotic Syndrome with and without Steroid Dependence

New England Journal of Medicine

Volumn 306, Issue 8, 1982, Pages 451-454

  Lennert, T ^a   Weber, H P ^b   Olbing, H ^c   Bachmann, H J ^c   Dippell, J ^d   Schindera, F ^e   Anders, D ^f   Blaker F ^g   Altrogge, H ^g   Brodehl, J ^h   Krohn, H P ^h   Scharer K ⁱ   Muller Wiefel D ⁱ   Jesberger, H J ^j   Joppich, R ^k   Diekmann, L ^l   Thoenes, W ^m   Schneider, B ^h  

^a Universitäts Kinderklinik ^*  (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITY HOSPITAL GIESSEN   (Germany)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^j SAARLAND UNIVERSITY   (Germany)

^k LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^l UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^m UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; PREDNISONE;

ADOLESCENT; DRUG THERAPY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MAJOR CLINICAL STUDY; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRESCHOOL CHILD; SCHOOL CHILD; THERAPY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHLORAMBUCIL; CLINICAL TRIALS; CYCLOPHOSPHAMIDE; FEMALE; HUMAN; MALE; NEPHROTIC SYNDROME; PREDNISONE; PROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; SUPPORT, NON-U.S. GOV'T;

EID: 0020079801     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198202253060803     Document Type: Article

References (29)

1. Etteldorf J.N., Roy S. III, Summitt R.L., Sweeney N.J., Wall H.P., Berton W.M. Cyclophosphamide in the treatment of idiopathic lipoid nephrosis. J Pediatr. 1967; 70:758-766
2. Moncrieff M.W., White R.H.R., Ogg C.S., Cameron J.S. Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J. 1969; 1:666-671
3. Chiu J., McLaine P.N., Drummond K.N. A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimallesion nephrotic syndrome in childhood. J Pediatr. 1973; 82:607-613
4. Prospective controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome: report of the International Study of Kidney Disease in Children. Lancet. 1974; 2:423-427
5. Pennisi A.J., Grushkin C.M., Lieberman E. Cyclophosphamide in the treatment of idiopathic nephrotic syndrome. Pediatrics. 1976; 57:948-951
6. Trompeter R.S., Barratt T.M., Kay R., Turner M.W., Soothill J.F. HLA, atopy, and cyclophosphamide in steroid-responsive childhood nephrotic syndrome. Kidney Int. 1980; 17:113-117
7. Lagrue G., Bariéty J., Canlorbe P., Vassal J., Milliez P. La chimiothérapie dite immuno-dépressive dans les syndromes néphrotiques primitifs de l#x0027;enfant. Presse Med. 1967; 75:1773-1777
8. Baluarte H.J., Hiner L., Gruskin A.B. Chlorambucil dosage in frequently relapsing nephrotic syndrome: a controlled clinical trial. J Pediatr. 1978; 92:295-298
9. Williams S.A., Makker S.P., Ingelfinger J.R., Grupe W.E. Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood. N Engl J Med. 1980; 302:929-933
10. Richter P., Calamera J.C., Morgenfeld M.C., Kierszenbaum A.L., Lavieri J.C., Mancini R.E. Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma. Cancer. 1970; 25:1026-1030
11. Fairley K.F., Barrie J.U., Johnson W. Sterility and testicular atrophy related to cyclophosphamide therapy. Lancet. 1972; 1:568-569
12. Penso J., Lippe B., Ehrlich R., Smith F.G. Jr. Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome. J Pediatr. 1974; 84:831-836
13. Pennisi A.J., Grushkin C.M., Lieberman E. Gonadal function in children with nephrosis treated with cyclophosphamide. Am J Dis Child. 1975; 129:315-318
14. Etteldorf J.N., West C.D., Pitcock J.A., Williams D.L. Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome. J Pediatr. 1976; 88:206-212
15. Guesry P., Lenoir G., Broyer M. Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome. J Pediatr. 1978; 92:299-303.
16. Callis L., Nieto J., Vila A., Rende J. Chlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicity. J Pediatr. 1980; 97:653-656
17. Slavin R.E., Millan J.C., Mullins G.M. Pathology of high dose intermittent cyclophosphamide therapy. Hum Pathol. 1975; 6:693-709.
18. Lenoir G., Guesry P., Kleinknecht C., Gagnadoux M.-F., Broyer M. Complications extragonadiques du chlorambucil chez l#x0027;enfant. Arch Fr Pediatr. 1977; 34:798-807.
19. Grünwald H.W., Rosner F. Acute leukemia and immunosuppressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseases. Arch Intern Med. 1979; 139:461-466
20. Casciato D.A., Scott J.L. Acute leukemia following prolonged cytotoxic agent therapy. Medicine (Baltimore). 1979; 58:32-47.
21. Müller W., Brandis M. Acute leukemia after cytotoxic treatment for nonmalignant disease in childhood: a case report and review of the literature. Eur J Pediatr. 1981; 136:105-108
22. Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early: a report of the International Study of Kidney Disease in Children. J Pediatr. 1979; 95:239-243
23. Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome: a report of “Arbeitsgemeinschaft für Pädiatrische Nephrologie.” Lancet. 1979; 1:401-403
24. Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome: a report of “Arbeitsgemeinschaft für Pädiatrische Nephrologie.” Eur J Pediatr. 1981; 135:229-237
25. Cutler S.J., Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958; 8:699-712.
26. Siegel N.J., Goldberg B., Krassner L.S., Hayslett J.P. Long-term follow-up of children with steroid-responsive nephrotic syndrome. J Pediatr. 1972; 81:251-258
27. Garin E.H., Pryor N.D., Fennell R.S. III, Richard G.A. Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy. J Pediatr. 1978; 92:304-308
28. Herin P., Eriksson M. Cytotoxic treatment in children with idiopathic nephrotic syndrome. Acta Paediatr Scand. 1980; 69:315-320
29. Kleinknecht C., Guesry P., Lenoir G., Broyer M. High-cost benefit of chlorambucil in frequently relapsing nephrosis. N Engl J Med. 1977; 296:48.